Blood Collection Biorepository for Liver Disease Research

The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Non-Alcoholic Steatohepatitis(NASH) Bariatric Surgery Candidate Blood-Borne Infections Body Weight Cirrhosis Communicable Diseases DNA Virus Infections Digestive System Diseases Fatty Liver Fibrosis Flaviviridae Infections Hepadnaviridae Infections Hepatitis Hepatitis B Hepatitis C Hepatitis, Viral, Human Infections Liver Diseases Non-alcoholic Fatty Liver Disease Nutrition Disorders Nutritional and Metabolic Diseases Obesity Obesity, Childhood Overnutrition Overweight Pathologic Processes Pathological Conditions, Signs and Symptoms Pediatric Obesity RNA Virus Infections Signs and Symptoms Virus Diseases

Age range

7 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University at Buffalo, Buffalo General Medical Center

Buffalo, New York, 14203, United States

Location status: Recruiting

Location contact

Barbara Bauer, BA

CONTACT

[email protected]

716-888-4825

About this study

The Biorepository at the University at Buffalo has been established to collect biological samples from patients with various types of liver disease. The objectives of this biorepository are to stimulate collaboration between clinicians and researchers, to bolster training of junior investigators and to promote multidisciplinary integration to advance translational medicine and to improve the health of patients all over the country. The purpose of this biorepository is to support investigators and to provide them with high quality specimens to promote their efforts in new discoveries or perfecting treatment of patients with liver diseases caused by Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), and Human Immunodeficiency Virus (HIV). The goal is to obtain samples that represent patients seen in the clinics of medical centers in Western NY and from some of the rarer diseases encountered in these clinics. The ultimate goal is to develop the biorepository as Western New York's resource for clinically annotated human samples that can be used to conduct research that could lead to significant advances in patient care.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples.
Children and teenagers will be special populations considered in this protocol.

Exclusion criteria

Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.

Treatment and study plan

Primary outcomes

Number of samples collected

Time frame: 52 weeks

Total number of samples collected

Study contacts

Contact information is provided by the study sponsor or research team.

Barbara Bauer, BA

CONTACT

[email protected]

716-888-4825

Sponsors and collaborators

Lead sponsor

State University of New York at Buffalo

Other

Registry information

Official study title

Virology, Immunology and Mechanisms of Liver Disease in Patients With Hepatitis C and Other Liver Diseases

Important dates

Study start: 2013
Primary completion: 2099
Study completion: 2099
First posted: Jan 19, 2017
Registry last updated: Aug 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed